Fosaprepitant Injection, Powder, Lyophilized, For Solution
Product Images NDC 72205-083

This is a pharmaceutical product labeled as Fosaprepitant for Injection, with a concentration of 150 mg per vial. The medication is in the form of a sterile lyophilized powder intended for intravenous use only after reconstitution and dilution with 5 mL of 0.9% sodium chloride for injection. It warns to not use solutions containing divalent cations as it includes lactated ringer's solution and Hartmann's solution. It is a single-dose vial, and any unused portion should be discarded. The product label has various codes such as GTIN, SIN, EXP, and LOT, which must be overcoded with 2D during packing. The medication should be refrigerated between 2°C-8°C (36°F - 46°F), and inactive ingredients in the product include edetate disodium, polysorbate 80, lactose anhydrous, and sodium hydroxide, and/or hydrochloric acid for pH adjustment. This medication is manufactured by MSN Laboratories Private Limited, Telangana, INDIA.*

Fosaprepitant for Injection is a sterile lyophilized powder used for intravenous treatment only after reconstitution and dilution. Each vial contains 150 mg and is a single-dose vial to be discarded if unused portion. The reconstituted final drug solution is stable for 24 hours at room temperature or refrigerated at 2°C to 8°C. The usual dosage varies, so see the prescribing information for more details. The manufacturer is MSN Laboratories Private Limited located in Telangana, India. The LOT and EXP details are over-coded during packing and are shown in a coding area of 17 x 21 mm.*